Last reviewed · How we verify
NCT02526576: SVF
A Phase II Double-blind, Randomized, Study to Assess the Efficacy of Facial Fat Grafts Supplemented With Autologous, Adipose Derived Stromal Vascular Fraction (SVF)
Phase 2 trial testing Stromal Vasular Fraction in Facial Atrophy in 34 participants. Completed in 1 July 2017.
1 July 2017
Quick facts
| Lead sponsor | Antria |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 34 |
| Start date | 1 August 2015 |
| Primary completion | 1 July 2017 |
| Estimated completion | 1 July 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Stromal Vasular Fraction — full drug profile →
- Biopsy — full drug profile →
Conditions studied
- Facial Atrophy — all drugs for Facial Atrophy →
Sponsor
Antria — full company profile →
Who can join
Adults 18 to 70, any sex, with Facial Atrophy. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Volume retention
Time frame: 12 months
To demonstrate that SVF administration, in concert with autologous facial fat grafts, is more efficacious, with regards to graft survival, than standard, non-SVF enhanced, autologous facial fat grafts
Sponsor's own description
This phase two, randomized, double-blind study is designed to demonstrate the enhanced efficacy of SVF-enriched autologous facial fat grafts, in relation to standard, non-SVF enriched, facial fat grafts by evaluating volumetric retention and contour of the engrafted region over the course of one year.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Mesenchymal Stem Cells from Adipose Tissue in Clinical Applications for Dermatological Indications and Skin Aging.
Gaur M, Dobke M, Lunyak VV. · · 2017 · cited 105× · PMID 28117680 · DOI 10.3390/ijms18010208 -
Concise Review: Fat and Furious: Harnessing the Full Potential of Adipose-Derived Stromal Vascular Fraction.
Dykstra JA, Facile T, Patrick RJ, Francis KR, et al · · 2017 · cited 77× · PMID 28186685 · DOI 10.1002/sctm.16-0337 -
The use of stem cells in aesthetic dermatology and plastic surgery procedures. A compact review of experimental and clinical applications.
Nowacki M, Kloskowski T, Pietkun K, Zegarski M, et al · · 2017 · cited 7× · PMID 29422816 · DOI 10.5114/ada.2017.72456
Verify or expand the search:
- PubMed search for NCT02526576
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02526576 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Antria
- Last refreshed: 25 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02526576.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing